Filing Details
- Accession Number:
- 0001179110-20-001470
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-11 19:03:59
- Reporting Period:
- 2020-02-07
- Accepted Time:
- 2020-02-11 19:03:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755174 | Ann Jo Beltramello | C/O Momenta Pharmaceuticals, Inc. 301 Binney St, Cambridge MA 02142 | Chief Hr And Inf. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Commonstock | Acquisiton | 2020-02-07 | 2,691 | $18.85 | 45,501 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-02-07 | 1,345 | $0.00 | 46,846 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-07 | 2,691 | $31.06 | 44,155 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-10 | 605 | $31.50 | 43,550 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-02-07 | 1,326 | $0.00 | 1,326 | $18.85 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-02-07 | 1,365 | $0.00 | 1,365 | $18.85 |
| Common Stock | Restricted Stock Units | Acquisiton | 2020-02-07 | 1,345 | $0.00 | 1,345 | $0.00 |
| Common Stock | Stock Option (right to Buy) | Acquisiton | 2020-02-07 | 75,000 | $0.00 | 75,000 | $31.87 |
| Common Stock | Restricted Stock Units | Acquisiton | 2020-02-07 | 37,500 | $0.00 | 37,500 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,541 | 2018-11-07 | 2027-02-07 | No | 4 | M | Direct |
| 24,128 | 2018-02-07 | 2027-02-07 | No | 4 | M | Direct |
| 5,382 | No | 4 | M | Direct | ||
| 75,000 | 2030-02-07 | No | 4 | A | Direct | |
| 37,500 | No | 4 | A | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- Restricted Stock Units convert into common stock on a one-for-one basis.
- Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
- Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated.
- Subject to certain criteria, the stock option will vest and become exercisable with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
- Represents restricted stock units granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated.
Billionaire Hedge Funds
